- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00815087
Functional Electrical Stimulation in Irradiated Nasopharyngeal Carcinoma (NPC)
Efficacy of Functional Electrical Stimulation in Dysphagia of Nasopharyngeal Cancer Post Radiotherapy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Nasopharyngeal carcinoma (NPC) patients usually underwent radiotherapy (RT) or chemoradiotherapy(CRT). There were some complications caused by RT, like dysphagia.
In recent studies, functional electrical stimulation (FES) was be used in neurologically dysphagia patients, and there were some positive effects with these studies. Hence, we decided applied FES to these NPC patients with dysphagia.
Study Type
Enrollment (Actual)
Phase
- Phase 2
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Primary nasopharyngeal carcinoma
- Post radiation therapy
- Mild to severe dysphagia
- Never underwent swallowing therapy
Exclusion Criteria:
- Recurrent cancer
- Neurological or degenerate disease
- Total or partial laryngectomy
- Epilepsy
- With cardiac pacemaker
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Functional Electrical Stimulation (FES)
Functional electrical stimulation: Experimental
|
15 sessions of VitalStim® therapy, 60 minutes per session
Other Names:
|
|
Active Comparator: Home Rehabilitation Program (HRP)
Exercise home program
|
Daily exercise training
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Change From Baseline and Cut Point VFSS in Velocity of Displacement of Hyoid Bone at 1 to 3 Months
Time Frame: Averaged 2 months
|
A parameter of the VFSS assessment was velocity of displacement of hyoid bone on 5mL thin barium sulfate bolus, which was defined as the displacement divided by the duration.
The outcome measure time frame was based on VFSS assessment with the range between one to three months due to subjects received 1 to 3 times per week.
We will provide the mean time frame, which is 2 months.
|
Averaged 2 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Questionnaire of Life Quality
Time Frame: 1 to 3 months
|
1 to 3 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Tyng-Guey Wang, MD, Department of Physicale Medicine and Rehabilitation, National Taiwan University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Carcinoma
- Neoplasms, Glandular and Epithelial
- Gastrointestinal Diseases
- Pharyngeal Neoplasms
- Otorhinolaryngologic Neoplasms
- Head and Neck Neoplasms
- Nasopharyngeal Diseases
- Pharyngeal Diseases
- Stomatognathic Diseases
- Otorhinolaryngologic Diseases
- Esophageal Diseases
- Nasopharyngeal Neoplasms
- Nasopharyngeal Carcinoma
- Deglutition Disorders
Other Study ID Numbers
- 200804032R
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.